Puritan Medical launches patent-pending swab products

NewsGuard 100/100 Score

Puritan Medical Products Company, the leading manufacturer of specialty tip medical/diagnostic swabs and applicators in North America, has announced the introduction of a new line of high performance flocked products. The new HydraFlock ™ and UltraFlock™ swabs both offer superior absorption capabilities coupled with extremely rapid release performance.

Both products are patent pending in Europe, where the applications for both have been published — refer to application #: EP 2 263 548 A2 & EP 2 263 549 A2.  Patent applications have also been filed in China, Japan, Canada, Australia, and the United States.

The development of these products is a direct result of Puritan's ongoing effort to meet the evolving needs of the diagnostic market, which has led to a rapid expansion of the company over the last two years.

"We've had to evolve and be diverse," says Timothy Templet, Executive Vice President of Sales.  "Human diagnostic testing is a fast changing market, and we're making the commitment to stay at the forefront of this market."

Puritan's unique proprietary process affords a combination of sophisticated fiber creation and innovative applications, yielding a specimen collection device with extremely high performance metrics.  This is achieved without the addition of fiber treatments, resulting in a sample collection device that's totally free of interfering substances which can negatively affect the integrity of the swab.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool 'TORCH' successfully identifies cancer origins in unknown primary cases